Wal-Drog Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Wal-Drog Sp. z o.o. (Poland)

Main Activities: Residential Building Construction | Nonresidential Building Construction

Secondary Activities: Highway, Street, and Bridge Construction | Foundation, Structure, and Building Exterior Contractors | Other Building Finishing Contractors | Site Preparation Contractors | Cement and Concrete Product Manufacturing | Coating, Engraving, Heat Treating, and Allied Activities | Lumber, Plywood, Millwork, and Wood Panel Merchant Wholesalers | Construction, Transportation, Mining, and Forestry Machinery and Equipment Rental and Leasing

Full name: Wal-Drog Sp. z o.o.

Profile Updated: May 27, 2025

Wal-Drog Sp. z o.o. is an enterprise located in Poland, with the main office in Magdalenki. The company operates in the Residential Building Construction industry. It was first established on February 23, 2021. In its most recent financial highlights, the company reported a net sales revenue increase of 239.45% in 2024. A growth of 118.37% was recorded in its total assets.

Headquarters
Magdalenki 5
Magdalenki; Wielkopolskie; Postal Code: 63-830

Contact Details: Purchase the Wal-Drog Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Wal-Drog Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Wal-Drog Sp. z o.o. report to view the information.

Incorporation Date:

February 23, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

95%

Company Performance

Financial values in the chart are available after Wal-Drog Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

239.45%▲

Total operating revenue

239.45%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total assets

118.37%▲

Total equity

N/A

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

-87.7%▼

Similar companies

Related EMIS Industry Reports